Swiss - Delayed Quote CHF
Newron Pharmaceuticals S.p.A. (NWRN.SW)
7.70
+0.38
+(5.19%)
At close: June 6 at 5:31:34 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 3 | 3 |
| Avg. Estimate | 0 | 0 | -1.1 | 0.68 |
| Low Estimate | 0 | 0 | -1.79 | -0.95 |
| High Estimate | 0 | 0 | 0.11 | 2.79 |
| Year Ago EPS | -- | -- | 0.85 | -1.1 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 3 | 3 |
| Avg. Estimate | -- | -- | 18.53M | 44.47M |
| Low Estimate | -- | -- | 7.4M | 7.9M |
| High Estimate | -- | -- | 33M | 107M |
| Year Ago Sales | -- | -- | 51.39M | 18.53M |
| Sales Growth (year/est) | -- | -- | -63.94% | 139.93% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -1.1 | 0.68 |
| 7 Days Ago | 0 | 0 | -1.1 | 0.68 |
| 30 Days Ago | 0 | 0 | -1.7 | -0.38 |
| 60 Days Ago | 0 | 0 | -0.83 | 0.85 |
| 90 Days Ago | 0 | 0 | -0.99 | 0.85 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NWRN.SW | -- | -- | -229.02% | 161.70% |
| S&P 500 | 13.13% | 2.46% | 7.55% | 14.08% |
Related Tickers
RLF.SW Relief Therapeutics Holding SA
2.2100
0.00%
SANN.SW Santhera Pharmaceuticals Holding AG
13.86
+5.48%
MOLN.SW Molecular Partners AG
2.9900
+1.36%
IDIA.SW Idorsia Ltd
2.0150
+0.75%
NXOA.BE Nicox SA
0.2260
-0.88%
IMR.BE AC Immune SA
1.7820
+18.80%
3AC.F Actinogen Medical Limited
0.0120
0.00%
5CV.HA CureVac NV
3.8120
-0.78%
P0F.F Egetis Therapeutics AB (publ)
0.3285
-5.06%
BT1.BE Bone Therapeutics SA
0.0018
0.00%